SCHEMBL4833202

SCHEMBL4833202

COC(=O)C1Cc2c(OC)cccc2N1S(=O)(=O)c1ccc(-c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 6/20 0.42
PLAU P00749 1/20 0.42
PLAT P00750 1/20 0.42
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
GAA P10253 1/20 0.40
LMNA P02545 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
SCN9A Q15858 4/20 0.39
CYP2C9 P11712 1/20 0.39
SCN8A Q9UQD0 1/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADAMTS7 Q9UKP4 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842800 0.92 RORC (0.44) RORCPLAUPLATHCRTR1HCRTR2
SCHEMBL4843043 0.87 ALDH1A1 (0.47) GAALMNAMAPTMEN1TSHR
SCHEMBL4840659 0.84 BACE1 (0.43) RORCHCRTR1HCRTR2NPC1CYP2C9
SCHEMBL4839181 0.84 BACE1 (0.43) RORCNPC1
SCHEMBL4841794 0.81 GHSR (0.42) GAALMNAMAPTMEN1TSHR
SCHEMBL4836363 0.81 MMP2 (0.41) GAALMNAMAPTMEN1TSHR
SCHEMBL4841399 0.80 RORC (0.41) RORCPLAUPLATHCRTR1HCRTR2
SCHEMBL4842585 0.80 RORC (0.38) RORCPLAUPLATHCRTR1HCRTR2
SCHEMBL4836738 0.80 ALDH1A1 (0.40) GAALMNAMAPTSCN9AMEN1
SCHEMBL4833211 0.78 ALDH1A1 (0.47) GAALMNAMAPTMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885PLAU 4576/4885PLAT 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.